Key result
Low-dose aspirin reduced the risk of preeclampsia in women with multiple gestations, but did not change the risk of severe preeclampsia or SGA neonates.
Why the study?
Does low-dose aspirin prevent preeclampsia and small for gestational age neonates in women with multiple gestations?
Meta-Analysis (n=898)
Does low-dose aspirin prevent preeclampsia and small for gestational age neonates in women with multiple gestations?
Low-dose aspirin reduces the risk of overall and mild preeclampsia in multiple gestations, though the overall quality of evidence is low.
Answers are grounded in this paper and cite their sources.
Supports prophylactic low-dose aspirin to mitigate preeclampsia risk in multiple gestations; extends established single-.
Objective The objective of this study was to estimate the effect of low-dose aspirin in multiple gestations to prevent preeclampsia and small for gestational age (SGA) neonates. Methods A systematic review and meta-analysis were performed through electronic database searches. Randomized controlled trials (RCTs) of women with multiple gestations assigned to receive aspirin or placebo or no treatment were included. Outcomes included preeclampsia (mild and severe) and SGA neonates. Relative risks (RR) with their 95% confidence intervals (CI) were calculated. Result Out of 6,853 citations, 6 RCTS, including 898 pregnancies, were included. We observed a significant reduction in the risk of preeclampsia (RR, 0.67; 95% CI, 0.48-0.94) and mild preeclampsia (RR, 0.44; 95% CI, 0.24-0.82) but not severe preeclampsia (RR, 1.02; 95% CI, 0.61-1.72) with low-dose aspirin. The risk of SGA was not changed (RR, 1.09; 95% CI, 0.80-1.47). The reduction of preeclampsia was not different between women randomized before (RR, 0.86; 95% CI, 0.41-1.81) or after 16 weeks' gestation (RR, 0.64; 95% CI, 0.43-0.96) (p = 0.50). Conclusion There is low level of evidence supporting the use of low-dose aspirin for the prevention of preeclampsia and SGA neonates in multiple gestations.
No takes yet. Share an insight, caveat, or question.
Bergeron et al. (2016) conducted a meta-analysis in multiple gestations (n=898). low-dose aspirin vs. placebo or no treatment was evaluated on preeclampsia (RR 0.67, 95% CI 0.48-0.94). Low-dose aspirin reduced the risk of preeclampsia in women with multiple gestations, but did not change the risk of severe preeclampsia or SGA neonates.
Synapse has enriched 10 related papers. Consider them for comparative context: